Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop
National Academies of Sciences, Engineering, and Medicine,Action Collaborative on Countering the U.S. Opioid Epidemic,Health and Medicine Division,Board on Health Care Services,Board on Health Sciences Policy
Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop
National Academies of Sciences, Engineering, and Medicine,Action Collaborative on Countering the U.S. Opioid Epidemic,Health and Medicine Division,Board on Health Care Services,Board on Health Sciences Policy
Methadone is a Food and Drug Administration- (FDA-) approved medication for treating opioid use disorder (OUD), a chronic brain disease that affects more than 2.7 million people in the United States aged 12 and older. Despite its effectiveness in saving lives, many barriers impede access to, initiation of, and retention in methadone treatment for OUD. To address these barriers, on March 3 and 4, 2022, the National Academies of Sciences, Engineering, and Medicine hosted a workshop on Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws, at the request of the Office of National Drug Control Policy in the Executive Office of the President. This publication summarizes the presentation and discussion of the workshop.
This item is not currently in-stock. It can be ordered online and is expected to ship in approx 4 weeks
Our stock data is updated periodically, and availability may change throughout the day for in-demand items. Please call the relevant shop for the most current stock information. Prices are subject to change without notice.
Sign in or become a Readings Member to add this title to a wishlist.